Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
98.59
-3.66 (-3.57%)
Aug 20, 2026, 10:48 AM EDT - Market open
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $6.4 billion as of August 20, 2026. Its market cap has increased by 95.55% in one year.
Market Cap
6.40B
Enterprise Value
6.73B
1-Year Change
95.55%
Ranking
Category
Stock Price
$98.59
ChartMarket Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $6.40B, an increase of 2,053.69%. That is a compound annual growth rate of 54.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 6.40B | 56.80% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 6.99B |
| CG Oncology | 6.84B |
| Cogent Biosciences | 6.57B |
| Dianthus Therapeutics | 6.42B |
| Belite Bio | 6.42B |
| Erasca | 6.39B |
| Scholar Rock Holding | 6.34B |
| Caris Life Sciences | 6.11B |